PSTV (Plus Therapeutics) Institutional Ownership: 6.64% (As of Jul. 08, 2026)


PSTV Plus Therapeutics Inc PSTV
28 GF Score
Price $3.96
! 2 Warning Signs
View Full Analysis

What is Plus Therapeutics Institutional Ownership?

Plus Therapeutics PSTV -3.09% 28 Institutional Ownership is 6.64% as of Jul. 08, 2026. GuruFocus rates PSTV with a GF Score™ of 28/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Plus Therapeutics's institutional ownership is 6.64%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Plus Therapeutics's Insider Ownership is 19.54%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Plus Therapeutics's Float Percentage Of Total Shares Outstanding is 99.65%.

Plus Therapeutics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Plus Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Plus Therapeutics Institutional Ownership Chart

Plus Therapeutics Historical Data

The historical data trend for Plus Therapeutics can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-06-30
Institutional Ownership 0.12 2.44 2.53 2.53 2.83 2.21 2.47 3.49 3.49 2.85
PSTV
28GF Score
Plus Therapeutics Inc PSTV
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Plus Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 6.64% mean?
Plus Therapeutics (PSTV) has a Institutional Ownership of 6.64% as of Jul. 08, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Plus Therapeutics and its competitors.
Is Plus Therapeutics' Institutional Ownership too high?
Plus Therapeutics' current Institutional Ownership is 6.64%. Overall, Plus Therapeutics has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Plus Therapeutics' Institutional Ownership compare to KYNB and VTGN?
Plus Therapeutics' Institutional Ownership of 6.64% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Plus Therapeutics and its competitors. Plus Therapeutics's current Institutional Ownership is 6.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Plus Therapeutics stock overvalued right now?
Plus Therapeutics (PSTV) has a current Institutional Ownership of 6.64%. The current Institutional Ownership is 6.64%. Plus Therapeutics' overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Plus Therapeutics (PSTV), the current Institutional Ownership is 6.64% as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Plus Therapeutics Business Description

Other Exchanges XMP1:Germany
Address 6420 Levit Green Boulevard, Suite 210, Houston, TX, USA, 77021
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
28GF Score

Get the complete analysis for PSTV

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.96
Price